The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese Patients With Acute Coronary Syndrome – Randomized, Double-Blind, Phase III PHILO Study –
Open accessAbstract
BACKGROUND: Few data on the relative efficacy and safety of new P2Y12inhibitors such as prasugrel and ticagrelor in Japanese, Taiwanese and South Korean patients with acute coronary syndromes (ACS) exist. METHODS AND RESULTS: The multicenter, double-blind, randomized PHILO trial compared the safety and efficacy of ticagrelor vs. clopidogrel in 801 patients with ACS (Japanese, n=721; Taiwanese, n=35; South Korean, n=44; unknown ethnicity, n=1). All were planned to undergo percutaneous coronary intervention and randomized within 24 h of symptom onset. Primary safety and efficacy endpoints were time to first occurrence of any major bleeding event and to any event from the composite of myocardial infarction, stroke or death from vascular causes, respectively.At 12 months, overall major bleeding occurred in 10.3% of ticagrelor-treated patients and in 6.8% of clopidogrel-treated patients (hazard ratio (HR), 1.54; 95% confidence interval (CI): 0.94-2.53); the composite primary efficacy endpoint occurred in 9.0% and in 6.3% of ticagrelor- and clopidogrel-treated patients, respectively (HR, 1.47; 95% CI: 0.88-2.44). For both analyses, the difference between groups was not statistically significant. CONCLUSIONS: In ACS patients from Japan, Taiwan and South Korea, event rates of primary safety and efficacy endpoints were higher, albeit not significantly, in ticagrelor-treated patients compared with clopidogrel-treated patients. This observation could be explained by the small sample size, imbalance in clinical characteristics and low number of events in the PHILO population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Self-citation(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Authors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A. A., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.612812 · Cited by 1,341
Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., et al. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.11.006 · Cited by 1,068
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
Alexander, J. H., Lopes, R. D., James, S., Kilaru, R., He, Y., Mohan, P., Bhatt, D. L., Goodman, S., Verheugt, F. W., Flather, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105819 · Cited by 1,005
Manoukian, S. V., Feit, F., Mehran, R., Voeltz, M. D., Ebrahimi, R., Hamon, M., Dangas, G. D., Lincoff, A. M., White, H. D., Moses, J. W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.027 · Cited by 798
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Tricoci, P., Huang, Z., Held, C., Moliterno, D. J., Armstrong, P. W., Van de Werf, F., White, H. D., Aylward, P. E., Wallentin, L., Chen, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109719 · Cited by 754
Cannon, C. P., Harrington, R. A., James, S., Ardissino, D., Becker, R. C., Emanuelsson, H., Husted, S., Katus, H., Keltai, M., Khurmi, N. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62191-7 · Cited by 664
Self-citationFox, K. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3081 · Cited by 599
Bhatt, D. L., Roe, M. T., Peterson, E. D., Li, Y., Chen, A. Y., Harrington, R. A., Greenbaum, A. B., Berger, P. B., Cannon, C. P., Cohen, D. J., et al. (2004) · JAMA · doi:10.1001/jama.292.17.2096 · Cited by 568
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Kimura, T., Morimoto, T., Nakagawa, Y., Tamura, T., Kadota, K., Yasumoto, H., Nishikawa, H., Hiasa, Y., Muramatsu, T., Meguro, T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808311 · Cited by 358
Self-citationLevine, G. N., Jeong, Y.-H., Goto, S., Anderson, J. L., Huo, Y., Mega, J. L., Taubert, K., & Smith, S. C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.104 · Cited by 337
Self-citationAdenosine-Mediated Effects of Ticagrelor
Cattaneo, M., Schulz, R., & Nylander, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.031 · Cited by 312
James, S. K., Roe, M. T., Cannon, C. P., Cornel, J. H., Horrow, J., Husted, S., Katus, H., Morais, J., Steg, P. G., Storey, R. F., et al. (2011) · BMJ · doi:10.1136/bmj.d3527 · Cited by 303
Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
Bonello, L., Laine, M., Kipson, N., Mancini, J., Helal, O., Fromonot, J., Gariboldi, V., Condo, J., Thuny, F., Frere, C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.067 · Cited by 283
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B., Lamm, D., O'Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 252
Armstrong, D., Summers, C., Ewart, L., Nylander, S., Sidaway, J. E., & van Giezen, J. J. J. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413511693 · Cited by 245
Goldberg, R. J., Currie, K., White, K., Brieger, D., Steg, P. G., Goodman, S. G., Dabbous, O., Fox, K. A. A., & Gore, J. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.006 · Cited by 201
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans
Wittfeldt, A., Emanuelsson, H., Brandrup-Wognsen, G., van Giezen, J. J. J., Jonasson, J., Nylander, S., & Gan, L.-M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.032 · Cited by 198
Self-citationTakii, T., Yasuda, S., Takahashi, J., Ito, K., Shiba, N., Shirato, K., Shimokawa, H., & on behalf of the MIYAGI-AMI Study Investigators (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0619 · Cited by 196
Ethnic Differences in Genetic Polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1
Ozawa, S., Soyama, A., Saeki, M., Fukushima-Uesaka, H., Itoda, M., Koyano, S., Sai, K., Ohno, Y., Saito, Y., & Sawada, J.-I. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.83 · Cited by 165
Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
O’Donoghue, M. L., Bhatt, D. L., Wiviott, S. D., Goodman, S. G., Fitzgerald, D. J., Angiolillo, D. J., Goto, S., Montalescot, G., Zeymer, U., Aylward, P. E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.000786 · Cited by 152
Self-citationDaida, H., Miyauchi, K., Ogawa, H., Yokoi, H., Matsumoto, M., Kitakaze, M., Kimura, T., Matsubara, T., Ikari, Y., Kimura, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0174 · Cited by 150
Self-citationGoto, S., Ogawa, H., Takeuchi, M., Flather, M. D., Bhatt, D. L., & on behalf of the J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq320 · Cited by 146
Self-citationNakatani, D., Sakata, Y., Suna, S., Usami, M., Matsumoto, S., Shimizu, M., Sumitsuji, S., Kawano, S., Ueda, Y., Hamasaki, T., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-11-1059 · Cited by 108
Park, D., Yun, S., Lee, S., Kim, Y., Lee, C. W., Hong, M., Cheong, S., Kim, J., Park, S., & Park, S. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.06.011 · Cited by 86
Self-citationMahaffey, K. W., Held, C., WOJDYLA, D. M., James, S. K., Katus, H. A., Husted, S., Steg, P. G., Cannon, C. P., Becker, R. C., Storey, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.038 · Cited by 54
Li, H., Butler, K. A., Li, Y., Yang, Z., & Teng, R. (2011) · Clinical Drug Investigation · doi:10.2165/11595930-000000000-00000 · Cited by 50
Ogawa, H., Goto, S., Matsuzaki, M., Hiro, S., Shima, D., & on behalf of the J-ROCKET AF study investigators (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0209 · Cited by 43
Self-citationLiang, Z., Han, Y., Zhang, X., Li, Y., Yan, C., & Kang, J. (2013) · EuroIntervention · doi:10.4244/eijv9i3a53 · Cited by 42
Hiasa, Y., Teng, R., & Emanuelsson, H. (2014) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-014-0277-1 · Cited by 41
Self-citationToda, E., & Goto, S. (2009) · Hämostaseologie · doi:10.1055/s-0037-1617131 · Cited by 24
Self-citationNew Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
Goto, S., & Tomita, A. (2014) · Clinical Cardiology · doi:10.1002/clc.22233 · Cited by 21
Self-citationGoto, S. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-06-0388 · Cited by 18
Self-citationOgawa, H., & Kojima, S. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2009.05.001 · Cited by 6
Cited by
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Self-citationJCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
Nakamura, M., Kimura, K., Kimura, T., Ishihara, M., Otsuka, F., Kozuma, K., Kosuge, M., Shinke, T., Nakagawa, Y., Natsuaki, M., et al. (2020) · Circulation Journal · doi:10.1253/circj.cj-19-1109 · Cited by 352
Self-citationAntiplatelet therapy after percutaneous coronary intervention
Angiolillo, D. A., Galli, M., Collet, J.-P., Kastrati, A., & O'Donoghue, M. O. (2022) · EuroIntervention · doi:10.4244/eij-d-21-00904 · Cited by 299
Metadata
- Authors
- Goto, S., Huang, C.-H., Park, S.-J., Emanuelsson, H., & Kimura, T.
- Venue
- Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2015
- Volume
- 79
- Issue
- 11
- Pages
- 2452-2460
- ISSN
- 1346-9843 (ISSN-L)
- 1347-4820
- OpenAlex
- W2102398982
- Cited by
- 279
- References
- 40
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.